Alphyn Biologics, Inc. — Form D
Alphyn Biologics, Inc. of ANNAPOLIS, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-15. The offering totals $5.2M, of which $5.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-15
- Form: D
- Accession: 0001802325-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.2M
- Amount sold: $5.2M
- Investors: 18
- Date of first sale: 2024-03-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-510576
Issuer
- Name: Alphyn Biologics, Inc.
- CIK: 0001802325
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3724 THOMAS POINT ROAD, ANNAPOLIS, MD, 21403
- Phone: (443) 994-0101
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Steven Pentelnik | Director | Annapolis, MD |
| Tony Shipley | Director | Cincinnati, OH |
| Steven Pentelnik | Executive Officer | Annapolis, MD |
| Jeffrey Kossak | Director | Annapolis, MD |
| Gary Pekoe | Director | Annapolis, MD |
| Gary Pekoe | Executive Officer | Annapolis, MD |
| Adel Mikhail | Director | Annapolis, MD |
| Roger Griggs | Director | Annapolis, MD |
| Neal Koller | Director | Annapolis, MD |
| Neal Koller | Executive Officer | Annapolis, MD |
Other filings by this issuer (3)
More